Valproate and spina bifida.
作者信息
Oakeshott P, Hunt G M
机构信息
Addenbrooke's Hospital, Cambridge.
出版信息
BMJ. 1989 May 13;298(6683):1300-1. doi: 10.1136/bmj.298.6683.1300.
Abstract
摘要
相似文献
1
Valproate and spina bifida.
BMJ. 1989 May 13;298(6683):1300-1. doi: 10.1136/bmj.298.6683.1300.
2
[Prenatal diagnosis of 4 cases of spina bifida in mothers treated with valproate].
J Genet Hum. 1987 Aug;35(4):231-5.
3
[Use of valproic acid in pregnancy: an indication for prenatal diagnosis of spina bifida].
Ned Tijdschr Geneeskd. 1984 Dec 29;128(52):2438-40.
4
Valproic acid and spina bifida.
Lancet. 1982 Nov 13;2(8307):1096. doi: 10.1016/s0140-6736(82)90018-6.
5
Valproate and spina bifida.
Practitioner. 1989 Sep 8;233(1474):1129.
6
Valproate and spina bifida.
Lancet. 1989 Mar 18;1(8638):611-2.
7
In-utero exposure to valproate and neural tube defects.
Lancet. 1986 Jun 14;1(8494):1392-3. doi: 10.1016/s0140-6736(86)91711-3.
8
Spina bifida and sodium valproate.
Med J Aust. 1983 Apr 30;1(9):401. doi: 10.5694/j.1326-5377.1983.tb136122.x.
9
Valproate, spina bifida, and birth defect registries.
Lancet. 1989 Feb 18;1(8634):381. doi: 10.1016/s0140-6736(89)91751-0.
10
Valproate teratogenicity.
Pediatrics. 1983 Jun;71(6):980.
引用本文的文献
1
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Toxicol Sci. 2016 Mar;150(1):161-8. doi: 10.1093/toxsci/kfv321. Epub 2015 Dec 29.
2
Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells.
Cell Death Dis. 2015 May 7;6(5):e1756. doi: 10.1038/cddis.2015.121.
3
Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry.
Pharmacoepidemiol Drug Saf. 2014 Aug;23(8):779-86. doi: 10.1002/pds.3659. Epub 2014 Jun 27.
4
Pregnancy, epilepsy, and anticonvulsants.
Dialogues Clin Neurosci. 2008;10(1):63-75. doi: 10.31887/DCNS.2008.10.1/bjsteinhoff.
5
Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Drug Saf. 1994 Jul;11(1):37-67. doi: 10.2165/00002018-199411010-00005.
6
Epilepsy in women of childbearing age.
BMJ. 1989 Sep 2;299(6699):581. doi: 10.1136/bmj.299.6699.581.
7
Sodium valproate in pregnancy.
BMJ. 1991 Jul 6;303(6793):56-7. doi: 10.1136/bmj.303.6793.56-c.
8
Sodium valproate, carbamazepine and spina bifida.
Br J Gen Pract. 1991 Nov;41(352):478-9.
本文引用的文献
1
Spina bifida and anencephaly: fewer patients, more problems.
Br Med J (Clin Res Ed). 1983 May 28;286(6379):1679-80. doi: 10.1136/bmj.286.6379.1679.
2
Valproate and birth defects.
Lancet. 1983 Nov 12;2(8359):1142. doi: 10.1016/s0140-6736(83)90656-6.
3
Valproic acid and spina bifida.
Lancet. 1982 Nov 13;2(8307):1096. doi: 10.1016/s0140-6736(82)90018-6.
4
Maternal valproic acid and congenital neural tube defects.
Lancet. 1982 Oct 23;2(8304):937. doi: 10.1016/s0140-6736(82)90908-4.
5
Spina bifida--a vanishing nightmare?
Arch Dis Child. 1985 Nov;60(11):1086-91. doi: 10.1136/adc.60.11.1086.
6
New animal model for the study of neural tube defects.
Z Kinderchir. 1987 Dec;42 Suppl 1:32-5.
7
Teratogen update: valproic acid.
Teratology. 1987 Jun;35(3):465-73. doi: 10.1002/tera.1420350319.
8
On the ability of birth defects monitoring to detect new teratogens.
Am J Epidemiol. 1987 Jul;126(1):136-43. doi: 10.1093/oxfordjournals.aje.a114645.
9
Unanswered questions on neural tube defects.
Br Med J (Clin Res Ed). 1987 Jan 3;294(6563):1-2. doi: 10.1136/bmj.294.6563.1.
10
Prescribing in pregnancy. Identifying abnormalities.
Br Med J (Clin Res Ed). 1986 Dec 6;293(6560):1485-8. doi: 10.1136/bmj.293.6560.1485.
Zotero 插件